Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 881 | 1,195 | 2,815 | 2,639 | 5,719 |
| Marketable Securities | 4,721 | 6,414 | 7,611 | 10,225 | 8,272 |
| TOTAL | $6,168 | $8,188 | $10,980 | $13,428 | $14,602 |
| Non-Current Assets | |||||
| Intangibles | 2,039 | 2,039 | 2,039 | 2,039 | 2,039 |
| Other Non-Current Assets | 119 | 127 | 24 | 32 | 236 |
| TOTAL | $2,158 | $2,166 | $2,063 | $2,071 | $2,275 |
| Total Assets | $8,326 | $10,354 | $13,043 | $15,499 | $16,877 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 907 | 690 | 1,268 | 889 | 569 |
| TOTAL | $940 | $721 | $1,291 | $921 | $603 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 87 | 96 | 0 | 0 | 6 |
| TOTAL | $87 | $96 | $N/A | $N/A | $6 |
| Total Liabilities | $1,027 | $817 | $1,291 | $921 | $609 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 538 | 538 | 538 | 532 | 481 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -45,226 | -42,793 | -40,310 | -37,237 | -34,788 |
| Other shareholders' equity | -203 | -203 | -203 | -199 | -201 |
| TOTAL | $7,299 | $9,537 | $11,752 | $14,578 | $16,268 |
| Total Liabilities And Equity | $8,326 | $10,354 | $13,043 | $15,499 | $16,877 |